Open Access funding enabled and organized by Projekt DEAL. This study was funded by the ADDF (Alzheimer’s Drug Discovery Foundation: Grant 201810-2017419) to FL and IZ, the Instituto Carlos III (grants CP16/00041 and PI19/00144) to FL, the Robert Koch Institute through funds from the German Federal Ministry of Health (grant no. 1369–341) to IZ, and the Alzheimer Forschung Initiative (AFI, project no. 20026) to MS


Project title
Open Access funding enabled and organized by Projekt DEAL. This study was funded by the ADDF (Alzheimer’s Drug Discovery Foundation: Grant 201810-2017419) to FL and IZ, the Instituto Carlos III (grants CP16/00041 and PI19/00144) to FL, the Robert Koch Institute through funds from the German Federal Ministry of Health (grant no. 1369–341) to IZ, and the Alzheimer Forschung Initiative (AFI, project no. 20026) to MS

Publications
(All)

Results 1-1 of 1 (Search time: 0.002 seconds).

Issue DateTitleAuthor(s)TypeAccess
12022Plasma Lipocalin 2 in Alzheimer's disease: potential utility in the differential diagnosis and relationship with other biomarkersHermann, Peter; Villar-Piqué, Anna; Schmitz, Matthias; Schmidt, Christian; Varges, Daniela; Goebel, Stefan; Bunck, Timothy; Lindemann, Hanna; Bogner, Carla; Santana, Isabel ; Baldeiras, Inês; Riggert, Joachim; Zerr, Inga; Llorens, FrancarticleopenAccess